Remove Biotech Remove Implementation Remove Scaling
article thumbnail

Benchmarks 2023: How We’re Doing

Chief Executive

A big contributing factor to this, of course, are the inflation-driven price increases companies are implementing. It’s no coincidence that these are also among the companies most likely to implement substantial price increases (7.5 Prices, Revenues According to our survey, 41 percent of U.S.

article thumbnail

Building Resilience in the Pharmaceutical Supply Chain: Lessons from the Pandemic?

Kotter Inc.

The COVID-19 pandemic created significant supply chain challenges as manufacturers and distribution channels shut down, pivoted, or significantly scaled back to fight the spread of the virus. Both Anders and Chris have life-long careers in the Pharma industry, holding senior roles in both Big Pharma and smaller biotech companies.

Biotech 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Productivity Is Soaring at Top Firms and Sluggish Everywhere Else

Harvard Business Review

Some argue that the low-hanging fruit has already been picked: the IT revolution has run its course and other new technologies like biotech have yet to make a major impact on our lives. Unfortunately, the most productive and dynamic firms do not always grow to optimal scale.

Biotech 15
article thumbnail

Run B2B Sales on Data, Not Hunches

Harvard Business Review

The answer lies in scale and approach. Methodically capturing, cataloging, and analyzing individual conversations on a large scale allows companies to turn anecdote into statistically robust, reliable data. How is this different from relying on anecdote and myth?

B2B 12
article thumbnail

How to Make Sure Agile Teams Can Work Together

Harvard Business Review

Often, this means connecting people across units or geographies doing similar work to yield benefits of scale, or identifying points where integrating different perspectives yields agile innovation. The network lens can help uncover specific points that if crossed could yield agility benefits, rather than inefficiently bridging all silos.

Biotech 15
article thumbnail

India Remakes Global Innovation

Harvard Business Review

In doing so, Dr Reddy's strengthens its core generic drugs business and boosts the custom manufacturing services it provides to Big Pharma and nimble biotech startups. Western firms are masters of structured approaches to innovation that deliver scale and efficiency. Eastern firms excel at more frugal and flexible forms of innovation.

Biotech 11
article thumbnail

The Innovation Health Care Really Needs: Help People Manage Their Own Health

Harvard Business Review

Our analysis of Pitchbook Data shows that more than $200 billion has been poured into health care venture capital, mostly in biotech, pharma, and devices where advances typically make health care more sophisticated — and expensive. Patients scoring a 4 require a specific action, such as immediate outreach from a health coach.